Table 3.
ROC analysis | Neutralization (PRNT50 ≥ 20) | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
19A | Alpha | Beta | Delta | ||||||||||||||
Se | Sp | PPV | NPV | Se | Sp | PPV | NPV | Se | Sp | PPV | NPV | Se | Sp | PPV | NPV | ||
QFN Ag1 | |||||||||||||||||
Threshold 1 | 0.15 IU/ml | 1.00 | 0.58 | 0.92 | 1.00 | 0.98 | 0.55 | 0.92 | 0.86 | 1.00 | 0.24 | 0.63 | 1.00 | 0.96 | 0.33 | 0.83 | 0.71 |
Threshold 2 | 0.50 IU/ml | 0.80 | 0.92 | 0.98 | 0.50 | 0.78 | 0.91 | 0.98 | 0.46 | 0.78 | 0.48 | 0.66 | 0.64 | 0.76 | 0.63 | 0.86 | 0.46 |
Threshold 3 | 2.00 IU/ml | 0.43 | 0.97 | 0.94 | 0.57 | 0.34 | 1.00 | 1.00 | 0.33 | ||||||||
QFN Ag2 | |||||||||||||||||
Threshold 1 | 0.15 IU/ml | 0.98 | 0.50 | 0.90 | 0.86 | 0.96 | 0.45 | 0.90 | 0.71 | 1.00 | 0.25 | 0.64 | 1.00 | 0.94 | 0.25 | 0.80 | 0.57 |
Threshold 2 | 0.70 IU/ml | 0.80 | 0.92 | 0.98 | 0.50 | 0.78 | 0.91 | 0.98 | 0.46 | 0.81 | 0.52 | 0.68 | 0.68 | 0.76 | 0.63 | 0.86 | 0.46 |
Threshold 3 | 3.00 IU/ml | 0.46 | 0.93 | 0.90 | 0.57 | 0.28 | 0.94 | 0.93 | 0.30 | ||||||||
QFN Ag1 + 2 | |||||||||||||||||
Threshold 1 | 0.25 IU/ml | 1.00 | 0.58 | 0.92 | 1.00 | 0.98 | 0.55 | 0.92 | 0.86 | 1.00 | 0.24 | 0.63 | 1.00 | 0.96 | 0.31 | 0.81 | 0.71 |
Threshold 2 | 1.20 IU/ml | 0.83 | 0.92 | 0.98 | 0.55 | 0.82 | 0.91 | 0.98 | 0.50 | 0.84 | 0.48 | 0.67 | 0.70 | 0.80 | 0.63 | 0.87 | 0.50 |
Threshold 3 | 4.60 IU/ml | 0.46 | 0.93 | 0.90 | 0.57 | 0.36 | 0.94 | 0.95 | 0.32 | ||||||||
Serology | |||||||||||||||||
Threshold 1 | 150 BAU/ml | 1.00 | 0.42 | 0.88 | 1.00 | 1.00 | 0.46 | 0.90 | 1.00 | 1.00 | 0.15 | 0.52 | 1.00 | 1.00 | 0.33 | 0.83 | 1.00 |
Threshold 2 | 850 BAU/ml | 0.77 | 0.92 | 0.98 | 0.48 | 0.75 | 0.91 | 0.98 | 0.44 | 0.80 | 0.57 | 0.70 | 0.70 | 0.75 | 0.73 | 0.90 | 0.48 |
Threshold 3 | 2500 BAU/ml | 0.20 | 0.89 | 0.70 | 0.47 | 0.21 | 1.00 | 1.00 | 0.28 |
ROC receiver operating characteristic, Se sensitivity, Sp specificity, PPV positive predictive value, NPV negative predictive value, QFN QuantiFERON SARS-CoV-2 Starter Set®